Elemene
- Generic Name
- Elemene
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
合并放、化疗对肺癌、肝癌、食管癌、鼻咽癌、脑瘤、骨转移癌等可以增强疗效，降低放、化疗的毒副反应；可用于介入、腔内化疗及癌性胸腹水的治疗。
- Associated Conditions
- -
- Associated Therapies
- -
Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 74
- Registration Number
- NCT05842746
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2020-12-19
- Target Recruit Count
- 30
- Registration Number
- NCT04674527
- Locations
- 🇨🇳
Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT03166553
- Locations
- 🇨🇳
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
🇨🇳Jinan Military General Hospital, Jinan, Shandong, China
🇨🇳Henan Medical University Cancer Hospital, Zhengzhou, Henan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath